1 |
SV2C
| 1件: ECM-receptor interaction ECM-receptor interaction | D11842
D11842
|
Padsevonil
| 1件: 149 149 |
2 |
GABBR1
| 7件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, GABAergic synapse, Taste transduction, Estrogen signaling pathway, GnRH secretion, Morphine addiction | D00241
D00241
|
Baclofen
| 7件: 2 2, 10, 13, 18, 65, 149, 206 |
3 |
HTR2A
| 5件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels | D07945
D07945
|
Fenfluramine
| 4件: 140 140, 144, 145, 149 |
4 |
HTR2B
| 5件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels | D07945
D07945
|
Fenfluramine
| 4件: 140 140, 144, 145, 149 |
5 |
HTR2C
| 5件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels | D07945
D07945
|
Fenfluramine
| 4件: 140 140, 144, 145, 149 |
6 |
MTNR1A
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Circadian entrainment | D08170
D08170
|
Melatonin
| 12件: 6 6, 8, 13, 37, 46, 49, 90, 97, 144, 145, 149, 202 |
7 |
MTNR1B
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Circadian entrainment | D08170
D08170
|
Melatonin
| 12件: 6 6, 8, 13, 37, 46, 49, 90, 97, 144, 145, 149, 202 |
8 |
SCN3A
| 1件: Taste transduction Taste transduction | D07299
D07299
|
Lacosamide
| 1件: 149 149 |
9 |
SCN9A
| 1件: Taste transduction Taste transduction | D07299
D07299
|
Lacosamide
| 1件: 149 149 |
10 |
SLC6A4
| 2件: Synaptic vesicle cycle Synaptic vesicle cycle, Serotonergic synapse | D07945
D07945
|
Fenfluramine
| 4件: 140 140, 144, 145, 149 |
11 |
SNAP25
| 2件: Synaptic vesicle cycle Synaptic vesicle cycle, Insulin secretion | D00783
D00783
|
Botulinum toxin type A
| 13件: 2 2, 5, 6, 7, 13, 15, 17, 36, 51, 70, 113, 149, 226 |
12 |
CACNA1I
| 7件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome | D01303
D01303
|
Flunarizine
| 4件: 58 58, 86, 149, 215 |
13 |
CACNA1I
| 7件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome | D07971
D07971
|
Flunarizine
| 4件: 58 58, 86, 149, 215 |
14 |
CACNA1H
| 7件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome | D01303
D01303
|
Flunarizine
| 4件: 58 58, 86, 149, 215 |
15 |
CACNA1H
| 7件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome | D07971
D07971
|
Flunarizine
| 4件: 58 58, 86, 149, 215 |
16 |
CACNA1G
| 8件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome | D01303
D01303
|
Flunarizine
| 4件: 58 58, 86, 149, 215 |
17 |
CACNA1G
| 8件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome | D07971
D07971
|
Flunarizine
| 4件: 58 58, 86, 149, 215 |
18 |
GABBR2
| 7件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, GABAergic synapse, Taste transduction, Estrogen signaling pathway, GnRH secretion, Morphine addiction | D00241
D00241
|
Baclofen
| 7件: 2 2, 10, 13, 18, 65, 149, 206 |
19 |
SV2B
| 1件: ECM-receptor interaction ECM-receptor interaction | D11842
D11842
|
Padsevonil
| 1件: 149 149 |
20 |
SV2A
| 1件: ECM-receptor interaction ECM-receptor interaction | D08879
D08879
|
Brivaracetam
| 2件: 149 149, 309 |
21 |
SV2A
| 1件: ECM-receptor interaction ECM-receptor interaction | D11842
D11842
|
Padsevonil
| 1件: 149 149 |